Anjali Patel, DO
Interventional Pain Medicine · Clifton, NJNPI 1891818530
Payments from drug & device makers
What this record shows
This record is dominated by grants: $2,710 of the $3,310 with a category attached, or 81.9%. Abbott accounts for 85.4% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $1,495, more than ten times the $94 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in NJ, where the typical reported total is $3,760.
Across 29 payments — averaging $114.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- AstraZeneca$124
- Boston Scientific$111
- Protega Pharmaceutials Inc$45
- Johnson & Johnson$39
- Virtus Pharmaceuticals LLC$32
- plus $133 from 7 others
What the payments were for
- Grants$2,71082%
- Food & beverage$60018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 9 | $2,827 |
| AstraZeneca | 1 | $124 |
| Boston Scientific | 4 | $111 |
| Protega Pharmaceutials Inc | 3 | $45 |
| Johnson & Johnson | 1 | $39 |
| Virtus Pharmaceuticals LLC | 2 | $32 |
| Si-bone, Inc. | 2 | $32 |
| Baudax Bio Inc. | 2 | $30 |
| Nalu Medical, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Nevro Corp. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASSURITY$577
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$385
- TACTICATH$385
- FARXIGA$124
How this compares
$3,310 in reported general payments places this provider in the 40th percentile of 82 interventional pain medicine providers in New Jersey.
See all interventional pain medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 114 | $2,647 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 107 | $2,288 |
| Gabapentin | 122 | $1,214 |
| Lidocaine | 22 | $625 |
| Cyclobenzaprine Hcl | 99 | $590 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $566 |
| Pregabalin | 41 | $561 |
| Celecoxib | 26 | $357 |
| Tizanidine Hcl | 24 | $278 |
| Naproxen | 40 | $276 |
| Morphine Sulfate | 12 | $243 |
| Tramadol Hcl | 38 | $149 |
| Zolpidem Tartrate | 12 | $121 |
| Meloxicam | 21 | $62 |
| Ibuprofen | 11 | $14 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Clifton
- Dev SinhaClifton$9K
- George HannaClifton$5K
- Rahul SoodClifton$4K
- Kyle MeleClifton$2K
- Sumeet AroraClifton$2K
- Ross NochimsonClifton$2K
- Roy LiuClifton$2K
- Youssef JosephsonWest Deptford$496K
- Ali ValimahomedHolmdel$415K
- Saurabh DangEdgewater$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.